Following enrollment, patients continued their usual diet for 3 days (usual-sodium intake period). A restricted-salt diet consisting of a 50 % reduction of daily sodium intake was then administered to all participants for 10 days (restricted-salt diet period) after dietician counseling. For each patient, 24-hour urine collections were obtained during the consecutive last 3 days of each period, allowing 24-hour urinary sodium (UNa), albumin (Ualb) and creatinine (Ucreat) excretion determinations at the end of the usual vs restricted-sodium intake periods. The mean was calculated for each period. Seated BP was measured thrice at 3-min intervals using a semi -automated device (dinamap1846, critikon, Tampa, FL, USA) after 10 min seated rest. Systolic BP (SBP) and diastolic BP (DBP) levels were then calculated from the mean of the 3 consecutive measures. The schematic representation of the study design is presented in supplementary Figure 1 .
Statistical analysis
In the functional study, variables before and after salt reduction in AA and non-AA participants were compared by Wilcoxon matched pairs signed rank test. Intergroup variations were compared using unpaired Mann-Whitney U test. Gene-environment interaction was estimated by comparing variation of variables between genotype groups using unpaired Mann-Whitney U test. In the upper-right triangle of the linkage disequilibrium (LD) matrix is given the extent of LD expressed in terms of D' which is the ratio of the unstandardized coefficient to its maximal/minimal value, while, in the lower-left triangle of this matrix, the LD is expressed in terms of r² statistics. All D' and r² were highly significant (p < 0.001) except for *, p=0.004 ; †, p=0.160; ‡, p=0.825; §, p=0.319. Data are means ± SD. */ †/ ‡ / number of patient for A 1 A 1 /A 1 A 2 /A 2 A 2 respectively. § P value from one-way ANOVA. Data are means ± SD. */ †/ ‡ / number of patient for A 1 A 1 /A 1 A 2 /A 2 A 2 respectively. § P value from one-way ANOVA. A: all patients (*P=0.006; † P =0.51; ‡ P =0.006); B: AA homozygote; * P =0.0117; C: G carriers * P =0.3980.
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